You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, July 2022
|
| DOI | 10.1136/jitc-2022-004695 |
| Pubmed ID | |
| Authors |
Rita C. Acúrcio, Sabina Pozzi, Barbara Carreira, Marta Pojo, Nuria Gómez-Cebrián, Sandra Casimiro, Adelaide Fernandes, Andreia Barateiro, Vitor Farricha, Joaquim Brito, Ana Paula Leandro, Jorge A R Salvador, Luís Graça, Leonor Puchades-Carrasco, Luís Costa, Ronit Satchi-Fainaro, Rita C. Guedes, Helena F. Florindo |
X Demographics
The data shown below were collected from the profiles of 48 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 12 | 25% |
| Portugal | 2 | 4% |
| Spain | 2 | 4% |
| India | 2 | 4% |
| Germany | 2 | 4% |
| Israel | 2 | 4% |
| Paraguay | 1 | 2% |
| France | 1 | 2% |
| Colombia | 1 | 2% |
| Other | 3 | 6% |
| Unknown | 20 | 42% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 32 | 67% |
| Scientists | 12 | 25% |
| Practitioners (doctors, other healthcare professionals) | 3 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 57 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 26% |
| Unspecified | 4 | 7% |
| Student > Ph. D. Student | 4 | 7% |
| Professor | 3 | 5% |
| Student > Bachelor | 2 | 4% |
| Other | 5 | 9% |
| Unknown | 24 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 8 | 14% |
| Chemistry | 5 | 9% |
| Unspecified | 4 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 7% |
| Biochemistry, Genetics and Molecular Biology | 4 | 7% |
| Other | 6 | 11% |
| Unknown | 26 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 224. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 August 2023.
All research outputs
#171,332
of 25,460,285 outputs
Outputs from Journal for Immunotherapy of Cancer
#36
of 3,436 outputs
Outputs of similar age
#5,139
of 435,687 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#4
of 120 outputs
Altmetric has tracked 25,460,285 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,436 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,687 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 120 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.